BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29888705)

  • 21. Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat.
    Kaspari M; Gutzmer R; Kiehl P; Dumke P; Kapp A; Brodersen JP
    Dermatology; 2002; 205(1):67-9. PubMed ID: 12145439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Queyrat erythroplasia accompanied by bladder cancer in a circumcised male.
    Öztürk S; Uçak H
    Indian J Med Res; 2014 Apr; 139(4):650-1. PubMed ID: 24927357
    [No Abstract]   [Full Text] [Related]  

  • 23. Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin.
    Kwitniewski M; Jankowski D; Jaskiewicz K; Dziadziuszko H; Juzeniene A; Moan J; Ma LW; Peksa R; Kunikowska D; Graczyk A; Kwasny M; Kaliszewski M; Glosnicka R
    Int J Cancer; 2009 Oct; 125(7):1721-7. PubMed ID: 19521986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythroplasia of Queyrat: treatment with topical 5-fluorouracil.
    Goette DK; Carson TE
    Cancer; 1976 Oct; 38(4):1498-502. PubMed ID: 991073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroplasia of Queyrat. Treatment with topically applied fluorouracil.
    Goette DK; Elgart M; DeVillez RL
    JAMA; 1975 Jun; 232(9):934-7. PubMed ID: 1173631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report.
    Schmitz L; Bierhoff E; Dirschka T
    Dermatology; 2014; 228(1):24-6. PubMed ID: 24135797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbon dioxide laser treatment of erythroplasia of Queyrat.
    Greenbaum SS; Glogau R; Stegman SJ; Tromovitch TA
    J Dermatol Surg Oncol; 1989 Jul; 15(7):747-50. PubMed ID: 2501369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
    Christensen E
    Stomatologija; 2013; 15(3):ii. PubMed ID: 24511763
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemopreventative thoughts for photodynamic therapy.
    Bissonnette R
    Dermatol Clin; 2007 Jan; 25(1):95-100. PubMed ID: 17126747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations on Bowen's disease and its fundamental histopathological particularities. Its relationship with Queyrat's erythroplasia.
    NICOLAU SG; BALUS L
    Rum Med Rev; 1961; 5():59. PubMed ID: 14479529
    [No Abstract]   [Full Text] [Related]  

  • 34. Review of erythroplasia of Queyrat and its treatment.
    Goette DK
    Urology; 1976 Oct; 8(4):311-5. PubMed ID: 788296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PHOTODYNAMIC TREATMENT WITH NANOEMULSIFIED 5-AMINOLEVULINIC ACID AND NARROW BAND RED LIGHT FOR FIELD CANCERIZATION DUE TO OCCUPATIONAL EXPOSURE TO ULTRAVIOLET LIGHT IRRADIATION.
    Wollina U; Gaber B; Koch A
    Georgian Med News; 2018 Jan; (274):138-143. PubMed ID: 29461242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ.
    Wieland U; Jurk S; Weissenborn S; Krieg T; Pfister H; Ritzkowsky A
    J Invest Dermatol; 2000 Sep; 115(3):396-401. PubMed ID: 10951274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pigmentation on photodynamic therapy.
    Apalla Z; Lallas A; Sotiriou E; Ioannides D
    Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
    [No Abstract]   [Full Text] [Related]  

  • 38. Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach.
    Proietti I; Michelini S; Skroza N; Bernardini N; Tolino E; Anzalone A; Colapietra D; Mambrin A; DI Fraia M; Marchesiello A; Balduzzi V; Porta N; Petrozza V; Potenza C
    Ital J Dermatol Venerol; 2021 Jun; 156(3):388-391. PubMed ID: 31804047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionated aminolevulinic acid-photodynamic therapy (PDT) provides additional evidence for the use of PDT for non-melanoma skin cancer.
    Gold MH
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):571-2. PubMed ID: 19415805
    [No Abstract]   [Full Text] [Related]  

  • 40. Photodynamic treatment of skin malignancies with aminolevulinic acid. Emphasis on anatomical observations and in vitro erythema visual assessment.
    Salasche SJ
    Dermatol Surg; 1997 Mar; 23(3):161. PubMed ID: 9145956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.